Submitted by endpointsnews6292 in business
Two biotech companies, Neumora and RayzeBio, hashed out their IPO plans Monday morning, detailing hopes to raise around $227 million and $206 million, respectively, in their Nasdaq debuts. The companies could enter the public market as soon as this week. Both…